Title
Kairos As Indeterminate Risk Management: The Pharmaceutical Industry'S Response To Bioterrorism
Keywords
Bioterrorism; Globalization; Kairos; Pharmaceutical; Risk
Abstract
The pharmaceutical industry's response to the threat of bioterrorism following 9-11 invoked the rhetorical notion of kairos as an urgent and ongoing opportunity not only to protect the nation but also to improve the industry's reputation and fortify its political power. Yet the notion of kairos as seizing an advantage - grounded in modernist assumptions about agency and control - is also complicated by the case history of big pharma's response, which left the industry vulnerable to heightened and additional risks. This case history suggests that kairos can be less about seizing an advantage than about indeterminately responding to shifting, unbounded, uncertain, unpredictable, and uncontrollable risks shaped by the processes of globalization.
Publication Date
5-1-2006
Publication Title
Quarterly Journal of Speech
Volume
92
Issue
2
Number of Pages
115-143
Document Type
Review
Personal Identifier
scopus
DOI Link
https://doi.org/10.1080/00335630600816938
Copyright Status
Unknown
Socpus ID
33746144523 (Scopus)
Source API URL
https://api.elsevier.com/content/abstract/scopus_id/33746144523
STARS Citation
Blake Scott, J., "Kairos As Indeterminate Risk Management: The Pharmaceutical Industry'S Response To Bioterrorism" (2006). Scopus Export 2000s. 8767.
https://stars.library.ucf.edu/scopus2000/8767